abstract |
One non-exclusive aspect of the invention provides a molecule that is improved from an antibody that binds to an antigen in an ion concentration dependent manner. Another non-exclusive aspect provides a safe and more favorable variant of the Fc region that has reduced binding to pre-existing ADA. Another non-exclusive aspect provides a novel IL-8 antibody that is superior as a drug system. |